Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The "Global Encephalopathy Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The Global Encephalopathy Treatment Market is anticipated to grow at a CAGR of 4.75% during the period 2019-2023.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the emergence of novel treatment targets for encephalopathy. Certain candidates are under investigation for the treatment of liver cirrhosis which is one of the leading causes of hepatic encephalopathy.

According to the report, one driver influencing this market is the driven by the rise in initiatives to increase the awareness about encephalopathy disease management and effective treatment of encephalopathy. Most of the programs aim at providing co-pay assistance, educational material for hepatic encephalopathy, and treatment adherence support. The growing availability of such patient awareness programs for assistance in the management and treatment of encephalopathy is expected to boost the growth of the global encephalopathy market.

Further, the report states that one challenge affecting this market is the adverse side effects associated with available drugs. The growth of the market is impeded by the adverse side effects such as severe stomach pain, diarrhea, and flatulence due to the available drugs for the treatment of encephalopathy.

Key Vendor

• Bausch Health

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: PIPELINE ANALYSIS

• Pipeline Analysis

PART 05: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY TYPE

• Market segmentation by type
• Comparison by type
• Hepatic encephalopathy - Market size and forecast 2018-2023
• Diabetic encephalopathy - Market size and forecast 2018-2023
• Infectious encephalopathy - Market size and forecast 2018-2023
• Others - Market size and forecast 2018-2023
• Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Americas - Market size and forecast 2018-2023
• EMEA - Market size and forecast 2018-2023
• APAC - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 12: MARKET TRENDS

• Emergence of novel treatment targets for encephalopathy
• Increase in FDA drug approval for diseases associated with encephalopathy
• Increase in adoption of technological advances for treating encephalopathy

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Market positioning of vendors
• Bausch Health

For more information about this report visit https://www.researchandmarkets.com/research/wtpgxp/encephalopathy?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.